With box warnings

Without box warnings

Branded

Generic

2 results

actemra
(tocilizumab)
Genentech, Inc.
Usage: ACTEMRA (tocilizumab) is indicated for treating moderately to severely active rheumatoid arthritis, giant cell arteritis, systemic sclerosis-associated interstitial lung disease, polyarticular and systemic juvenile idiopathic arthritis, severe cytokine release syndrome, and COVID-19 in hospitalized adults receiving systemic corticosteroids.
ofev
(nintedanib)
Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: OFEV is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases with a progressive phenotype, and to slow pulmonary function decline in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD).

Medications for Interstitial Lung Disease Due To Systemic Disease

actemra